Manufacturer of Controlled Substances; Notice of Registration, 10314 [2010-4719]
Download as PDF
<![CDATA[
10314
Federal Register / Vol. 75, No. 43 / Friday, March 5, 2010 / Notices
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–4728 Filed 3–4–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated October 20, 2009, and
published in the Federal Register on
October 28, 2009, (74 FR 55588),
Aldrich Chemical Company, Inc., DBA
Isotec, 3858 Benner Road, Miamisburg,
Ohio 45342–4304, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedules I and II:
erowe on DSK5CLS3C1PROD with NOTICES
Drug
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Tetrahydrocannabinols (7370) .....
2,5-Dimethoxyamphetamine
(7396).
Psilocyn (7438) .............................
Normorphine (9313) .....................
Acetylmethadol (9601) .................
Alphacetylmethadol except levo–
alphacetylmethadol (9603).
Normethadone (9635) ..................
Norpipanone (9636) .....................
3-Methylfentanyl (9813) ................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
1-Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
1Piperidinocyclohexanecarbonitrile (8603).
Cocaine (9041) .............................
VerDate Nov<24>2008
14:45 Mar 04, 2010
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
Jkt 220001
Drug
Schedule
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Meperidine intermediate-A (9232)
Meperidine intermediate-B (9233)
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk, (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to produce isotope labeled
standards for drug testing and analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Aldrich Chemical Company Inc., to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Aldrich Chemical Company
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Tetrahydrocannabinols (7370) .....
3,4Methylenedioxymethamphetamine (MDMA) (7405).
Cocaine (9041) .............................
Oxycodone (9143) ........................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Schedule
I
I
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances as bulk
reagents for use in drug abuse testing.
No comments or objections have been
received. DEA has considered the
factors in 21 USC 823(a) and determined
that the registration of Lin Zhi
International Inc., to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Lin Zhi International Inc.,
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 USC 823, and
in accordance with 21 CFR 1301.33, the
above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–4719 Filed 3–4–10; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2010–4723 Filed 3–4–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated September 17, 2009,
and published in the Federal Register
on September 25, 2009, (74 FR 49020),
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
By Notice dated October 16, 2009, and
published in the Federal Register on
October 28, 2009, (74 FR 55586), Lin
Zhi International Inc., 687 North
Pastoria Avenue, Sunnyvale, California
94085, made application by renewal to
the Drug Enforcement Administration
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
E:\FR\FM\05MRN1.SGM
05MRN1
]]>Agencies
[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Page 10314]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4719]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 16, 2009, and published in the Federal
Register on October 28, 2009, (74 FR 55586), Lin Zhi International
Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
3,4-Methylenedioxymethamphetamine (MDMA) I
(7405).
Cocaine (9041)............................. II
Oxycodone (9143)........................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
as bulk reagents for use in drug abuse testing.
No comments or objections have been received. DEA has considered
the factors in 21 USC 823(a) and determined that the registration of
Lin Zhi International Inc., to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Lin Zhi International Inc., to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 USC 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-4719 Filed 3-4-10; 8:45 am]
BILLING CODE 4410-09-P
